financetom
Business
financetom
/
Business
/
Amicus Therapeutics' Q4 Non-GAAP Earnings, Net Product Revenue Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Amicus Therapeutics' Q4 Non-GAAP Earnings, Net Product Revenue Rise
Feb 19, 2025 5:12 AM

07:33 AM EST, 02/19/2025 (MT Newswires) -- Amicus Therapeutics ( FOLD ) reported Q4 non-GAAP earnings Wednesday of $0.09 per diluted share, up from $0.01 a year earlier.

Analysts polled by FactSet expected $0.10.

Net product revenue for the quarter that ended Dec. 31 was $149.7 million, up from $115.1 million a year earlier.

Analysts surveyed by FactSet expected $147.9 million.

Shares were up more than 1% in recent premarket activity Wednesday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved